Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mustafa, Sakhi"'
Autor:
James Lindsay, Mizuki Nishino, Biagio Ricciuti, Mark M. Awad, Joao V Alessi, Bijaya Sharma, Kathleen Pfaff, Kristen D Felt, Stephanie L Alden, Arrien A Bertram, Jessica J Lin, Mustafa Sakhi, Victor R Vaz, Madison M Turner, Scott J. Rodig, Justin F. Gainor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/df45c1dc462e495da677e1986b11220f
Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
Autor:
Catherine B. Meador, Vivek Naranbhai, Grace Hambelton, Julia Rivera, Christopher S. Nabel, Rebecca Lewinsohn, Mustafa Sakhi, Alejandro B. Balazs, A. John Iafrate, Justin F. Gainor
Publikováno v:
Clinical Lung Cancer. 24:353-359
Autor:
Arvind Ravi, Matthew D. Hellmann, Monica B. Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai, Chip Stewart, Ignaty Leshchiner, Jaegil Kim, Yo Akiyama, Aaron T. Griffin, Natalie I. Vokes, Mustafa Sakhi, Vashine Kamesan, Hira Rizvi, Biagio Ricciuti, Patrick M. Forde, Valsamo Anagnostou, Jonathan W. Riess, Don L. Gibbons, Nathan A. Pennell, Vamsidhar Velcheti, Subba R. Digumarthy, Mari Mino-Kenudson, Andrea Califano, John V. Heymach, Roy S. Herbst, Julie R. Brahmer, Kurt A. Schalper, Victor E. Velculescu, Brian S. Henick, Naiyer Rizvi, Pasi A. Jänne, Mark M. Awad, Andrew Chow, Benjamin D. Greenbaum, Marta Luksza, Alice T. Shaw, Jedd Wolchok, Nir Hacohen, Gad Getz, Justin F. Gainor
Publikováno v:
Nature Genetics. 55:807-819
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we describe here the first jo
Autor:
Andrew J. Piper-Vallillo, MD, Meghan J. Mooradian, MD, Catherine B. Meador, MD, PhD, Beow Y. Yeap, ScD, Jennifer Peterson, BS, Mustafa Sakhi, BS, MS, Andrew Do, BS, Leyre Zubiri, MD, Sara Stevens, NP, Jeanne Vaughn, NP, Kelly Goodwin, NP, Alexander Gavralidis, MD, Henning Willers, MD, Adam Miller, MD, Anna Farago, MD, PhD, Zofia Piotrowska, MD, MHS, Jessica J. Lin, MD, Ibiayi Dagogo-Jack, MD, Inga T. Lennes, MD, MPH, MBA, Lecia V. Sequist, MD, MPH, Jennifer S. Temel, MD, Rebecca S. Heist, MD, Subba Digumarthy, MD, Kerry L. Reynolds, MD, Justin F. Gainor, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100124- (2021)
Introduction: Lung cancer is associated with severe coronavirus disease 2019 (COVID-19) infections. Symptom overlap between COVID-19 and lung cancer may complicate diagnostic evaluation. We aimed to investigate the incidence, symptoms, differential d
Externí odkaz:
https://doaj.org/article/899d24b36a34456388b6d820eedce98b
Autor:
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, Vjola Jorgji, Peter Richieri, Katherine H. Xu, Roopa Madhu, Milan Parikh, Izabella Zamora, Arnav Mehta, Christopher S. Nabel, Samuel S. Freeman, Joshua D. Pirl, Chenyue Lu, Catherine B. Meador, Jaimie L. Barth, Mustafa Sakhi, Alexander L. Tang, Siranush Sarkizova, Colles Price, Nicolas F. Fernandez, George Emanuel, Jiang He, Katrina Van Raay, Jason W. Reeves, Keren Yizhak, Matan Hofree, Angela Shih, Moshe Sade-Feldman, Genevieve M. Boland, Karin Pelka, Martin Aryee, Ilya Korsunsky, Mari Mino-Kenudson, Justin F. Gainor, Nir Hacohen
Publikováno v:
bioRxiv
The organization of immune cells in human tumors is not well understood. Immunogenic tumors harbor spatially-localized multicellular ‘immunity hubs’ defined by expression of the T cell-attracting chemokinesCXCL10/CXCL11and abundant T cells. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34a8311fe1a0ffaf6c8bf19497a54e4
https://europepmc.org/articles/PMC10104028/
https://europepmc.org/articles/PMC10104028/
Autor:
Ryan B. Corcoran, Rebecca S. Heist, Aaron N. Hata, Liron Bar-Peled, Giulia Siravegna, Jochen K. Lennerz, Samuel J. Klempner, Justin F. Gainor, Dejan Juric, Islam Baiev, Mustafa Sakhi, Katerina A. Fella, Mohammed U. Syed, Alexa G. Michel, Lesli A. Kiedrowski, Junbing Zhang, Meagan B. Ryan, Chendi Li, Jessica J. Lin, Noritaka Tanaka
Mutant-selective KRASG12C inhibitors, such as MRTX849 (adagrasib) and AMG 510 (sotorasib), have demonstrated efficacy in KRASG12C-mutant cancers, including non–small cell lung cancer (NSCLC). However, mechanisms underlying clinical acquired resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6aa2acd4b997a9e54783ae8dd826d4
https://doi.org/10.1158/2159-8290.c.6549266
https://doi.org/10.1158/2159-8290.c.6549266
Autor:
Matthew D. Hellmann, Regina Barzilay, Justin F. Gainor, Adam Yala, Gregory J. Riely, Mark G. Kris, Jeffrey Girshman, Michelle S. Ginsberg, Subba R. Digumarthy, Kevin B. Huang, Mustafa Sakhi, Andrew J. Plodkowski, Hira Rizvi, Jia Luo, Anh Tuan Luu, Kathryn C. Arbour
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e9757109869bd89ac21fcbb8f97439
https://doi.org/10.1158/2159-8290.22535993
https://doi.org/10.1158/2159-8290.22535993
Autor:
Matthew D. Hellmann, Regina Barzilay, Justin F. Gainor, Adam Yala, Gregory J. Riely, Mark G. Kris, Jeffrey Girshman, Michelle S. Ginsberg, Subba R. Digumarthy, Kevin B. Huang, Mustafa Sakhi, Andrew J. Plodkowski, Hira Rizvi, Jia Luo, Anh Tuan Luu, Kathryn C. Arbour
Real-world evidence (RWE), conclusions derived from analysis of patients not treated in clinical trials, is increasingly recognized as an opportunity for discovery, to reduce disparities, and to contribute to regulatory approval. Maximal value of RWE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9221119c535f742a9cce4eaa37329a9e
https://doi.org/10.1158/2159-8290.c.6548006.v1
https://doi.org/10.1158/2159-8290.c.6548006.v1
Autor:
Ryan B. Corcoran, Rebecca S. Heist, Aaron N. Hata, Liron Bar-Peled, Giulia Siravegna, Jochen K. Lennerz, Samuel J. Klempner, Justin F. Gainor, Dejan Juric, Islam Baiev, Mustafa Sakhi, Katerina A. Fella, Mohammed U. Syed, Alexa G. Michel, Lesli A. Kiedrowski, Junbing Zhang, Meagan B. Ryan, Chendi Li, Jessica J. Lin, Noritaka Tanaka
Supplementary Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a96c09e6d29bcd6766cf1adc0dadec
https://doi.org/10.1158/2159-8290.22540040.v1
https://doi.org/10.1158/2159-8290.22540040.v1
Autor:
Trenton Reinicke, Justin F. Gainor, Marissa N Bruno, Henning Willers, Erika Nakajima, Anand S. Dighe, Yi-Bin Chen, Vivek Naranbhai, Leyre Zubiri, Aleigha Lawless, Brittany Y Bertaux, Aditya Bardia, Kerry L. Reynolds, Rebecca R. Saff, Jocelyn R. Farmer, Kerri St. Denis, A. John Iafrate, Elizabeth Niehoff, Joan How, Mustafa Sakhi, Grace Kirkpatrick, Arthur Y. Kim, Wilfredo-Garcia Beltran, Alejandro B. Balazs, Alexander Gavralidis, Caroline Barabell, Monica A Jackson, C. Bowes, Lailoo A Perriello, Amir T. Fathi, Andrew M. Brunner, Evan C. Lam, Gabriela S. Hobbs, Grace Hambelton, Christian N Nambu, Kimberly G. Blumenthal, Julia Thierauf, Laura Spring, Elyssa Denault, Claire A. Pernat, Steven J. Isakoff, Ryan J. Sullivan, Cristhian J Berrios-Mairena, Jennifer L Peterson, Lindsey Mortensen, Onosereme Ofoman
Publikováno v:
Journal of Clinical Oncology. 40:12-23
PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood. METHODS We performed a prospective cohort study of adults with solid-organ or hematologic cancers to evaluate anti–SARS-CoV-2 immuno